Orhan Korkmaz, MD, PhD
Postdoctoral Fellow (previously held)
Boston University Chobanian & Avedisian School of Medicine
Anatomy & Neurobiology



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Korkmaz OT, Saydam F, Dalkiran B, Degirmenci I, Tunçel N. Vasoactive Intestinal Peptide (VIP) and its Receptors in Adipose Tissue: Implications for Cold Stress Adaptation. Cell Biochem Biophys. 2024 Nov 17. PMID: 39550744
     
  2. Akan T, Aydin Y, Korkmaz OT, Ulupinar E, Saydam F. The Effects of Carvacrol on Transient Receptor Potential (TRP) Channels in an Animal Model of Parkinson's Disease. Neurotox Res. 2023 Dec; 41(6):660-669. PMID: 37452911
     
  3. Korkmaz OT. Can Brain-derived Neurotrophic Factor (BDNF) Mimetics be a Way Out for Neurodegenerative Diseases? Curr Pharm Des. 2023; 29(4):246-250. PMID: 36705236
     
  4. Korkmaz OT, Arkan S, Öncü-Kaya EM, Ates N, Tunçel N. Vasoactive intestinal peptide (VIP) conducts the neuronal activity during absence seizures: GABA seems to be the main mediator of VIP. Neurosci Lett. 2021 11 20; 765:136268. PMID: 34571088
     
  5. Öncü Kaya EM, Korkmaz OT, Yeniceli Ugur D, Sener E, Tunçel AN, Tunçel M. Determination of Ochratoxin-A in the brain microdialysates and plasma of awake, freely moving rats using ultra high performance liquid chromatography fluorescence detection method. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Sep 01; 1125:121700. PMID: 31302476
     
  6. Korkmaz OT, Ay H, Aytan N, Carreras I, Kowall NW, Dedeoglu A, Tuncel N. Vasoactive Intestinal Peptide Decreases ß-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease. J Mol Neurosci. 2019 Jul; 68(3):389-396.View Related Profiles. PMID: 30498985
     
  7. Korkmaz OT, Tunçel N. Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease. Curr Pharm Des. 2018; 24(39):4693-4701. PMID: 30636594
     
  8. Yelkenli IH, Ulupinar E, Korkmaz OT, Sener E, Kus G, Filiz Z, Tunçel N. Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats. J Mol Neurosci. 2016 Jun; 59(2):280-9. PMID: 27115671; DOI: 10.1007/s12031-016-0757-0;
     
  9. Korkmaz OT, Aytan N, Carreras I, Choi JK, Kowall NW, Jenkins BG, Dedeoglu A. 7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis. Neurosci Lett. 2014 Apr 30; 566:286-91.View Related Profiles. PMID: 24637017; PMCID: PMC5906793; DOI: 10.1016/j.neulet.2014.02.058;
     
  10. Korkmaz O, Ay H, Ulupinar E, Tunçel N. Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats. J Mol Neurosci. 2012 Nov; 48(3):565-73. PMID: 22544516
     
Showing 10 of 14 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 14 publications over 11 distinct years, with a maximum of 2 publications in 2009 and 2018 and 2023

YearPublications
20092
20101
20111
20121
20141
20161
20182
20191
20211
20232
20241

Contact for Mentoring:

Korkmaz's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (83) concept(s)
_
Co-Authors
See all (4) people
_
Similar People
See all (60) people
_
Same Department
Search Department